Jaguar Health supplement raises 2014 Plan share reserve sixfold to 2,273,154 shares
Jaguar Health filed a supplement to its proxy statement for the November 6, 2026 special meeting, disclosing a six-fold increase in shares available under its 2014 Stock Incentive Plan. The adjustment offsets dilution from the Series R Preferred Stock dividend and conversion, and it takes effect after the meeting if stockholders approve Proposal 3. Shareholders should note that the filing does not change the proposals or the board's recommendations.
Key points
- Share Reserve Adjustment raises 2014 Plan shares to 2,273,154 if Proposal 3 is approved, up from 378,859 proposed in the proxy statement
- Without approval, the 2014 Plan would have 4,260 shares available, up from 710 shares, per the filing
- Series R Preferred Stock converts to five common shares per preferred share on November 2, 2026
- Special meeting is scheduled for November 6, 2026
The filing
Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 28, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.